0001654954-21-009217.txt : 20210818 0001654954-21-009217.hdr.sgml : 20210818 20210818202918 ACCESSION NUMBER: 0001654954-21-009217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210817 FILED AS OF DATE: 20210818 DATE AS OF CHANGE: 20210818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OLIPHANT LAURA CENTRAL INDEX KEY: 0001783244 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22893 FILM NUMBER: 211188138 MAIL ADDRESS: STREET 1: C/O AEHR TEST SYSTEMS STREET 2: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS CENTRAL INDEX KEY: 0001040470 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942424084 STATE OF INCORPORATION: CA FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 5106239400 MAIL ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-08-17 0001040470 AEHR TEST SYSTEMS AEHR 0001783244 OLIPHANT LAURA C/O AEHR TEST SYSTEMS 400 KATO TERRACE FREMONT CA 94539 true Common Stock 2021-08-17 4 M false 7500 1.68 A 7500 D Common Stock 2021-08-17 4 M false 10000 1.77 A 17500 D Common Stock 2021-08-17 4 M false 7500 1.34 A 25000 D Common Stock 2021-08-17 4 S false 25000 5.3016 D 0 D Common Stock 30376 I by Trust Non-Qualified Stock Option (right to buy) 1.34 2021-08-17 4 M false 7500 0 D 2020-11-20 2027-10-20 Common Stock 7500 2500 D Non-Qualified Stock Option (right to buy) 1.68 2021-08-17 4 M false 7500 0 D 2019-08-17 2026-07-17 Common Stock 7500 7500 D Non-Qualified Stock Option (right to buy) 1.77 2021-08-17 4 M false 10000 0 D 2019-11-22 2026-10-22 Common Stock 10000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Exhibit 24 - Power of Attorney /s/ Kenneth B. Spink, Attorney-in-fact 2021-08-18 EX-24 2 powerattorneyloliphant.htm POWER OF ATTORNEY powerattorneyloliphant
  Exhibit 24
 
 
 
                           POWER OF ATTORNEY
 
The undersigned, as a Section 16 reporting person of Aehr
Test Systems (the "Company"), hereby constitutes and appoints
Gayn Erickson, Kenneth B. Spink and Vernon Rogers, and each of them,
the undersigned's true and lawful attorney-in-fact to:
 
      1. complete and execute Forms 3, 4 and 5 and other forms
         and all amendments thereto as such attorney-in-fact
         shall in his or her discretion determine to be required
         or advisable pursuant to Section 16 of the Securities
         and Exchange Act of 1934 (as amended) and the rules and
         regulations promulgated thereunder, or any successor
         laws and regulations, as a consequence of the
         undersigned's ownership, acquisition or disposition of
         securities of the Company; and
 
      2. do all acts necessary in order to file such forms with
         the Securities and Exchange Commission, any securities
         exchange or national association, the Company and such
         other person or agency as the attorney-in-fact shall
         deem appropriate.
 
The undersigned hereby ratifies and confirms all that said
attorney-in-fact and agents shall do or cause to be done by virtue
hereof. The undersigned acknowledges that the foregoing
attorney-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of
the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 (as amended).
 
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4 and
5 with respect to the undersigned's holdings and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the Company and the
foregoing attorneys-in-fact.
 
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 17th day of July, 2019.
 
 
Signature:                   /S/ LAURA OLIPHANT
                                        ----------------------
 
Print Name:                 LAURA OLIPHANT
                                        ----------------------